This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2024 Nov 19;332(19):1621-1622.

doi: 10.1001/jama.2024.8611.

Fecal Immunochemical Test and Helicobacter pylori Stool Antigen Co-Testing: A Potential Approach for Gastric Cancer Screening

M Constanza Camargo¹

Affiliations

PMID: 39348151
DOI: 10.1001/jama.2024.8611

Comment

Fecal Immunochemical Test and Helicobacter pylori Stool Antigen Co-Testing: A Potential Approach for Gastric Cancer Screening

M Constanza Camargo. JAMA. 2024.

. 2024 Nov 19;332(19):1621-1622.

doi: 10.1001/jama.2024.8611.

Author

M Constanza Camargo¹

Affiliation

¹ Division of Cancer Epidemiology and Prevention, National Cancer Institute, Rockville, Maryland.

PMID: 39348151
DOI: 10.1001/jama.2024.8611

No abstract available

PubMed Disclaimer

Comment on

Screening for Helicobacter pylori to Prevent Gastric Cancer: A Pragmatic Randomized Clinical Trial.
Lee YC, Chiang TH, Chiu HM, Su WW, Chou KC, Chen SL, Yen AM, Fann JC, Chiu SY, Chuang SL, Chen YR, Chen SD, Hu TH, Fang YJ, Wu MS, Chen TH, Yeh YP; Collaborators of Taiwan Community-based Integrated Screening Group. Lee YC, et al. JAMA. 2024 Nov 19;332(19):1642-1651. doi: 10.1001/jama.2024.14887. JAMA. 2024. PMID: 39348147 Free PMC article. Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems